Ligand-, Cell-, and Estrogen Receptor Subtype (α/β)-dependent Activation at GC-rich (Sp1) Promoter Elements*
- Brad Saville‡,
- Mark Wormke‡,
- Fan Wang‡,
- Thu Nguyen‡,
- Eva Enmark§,
- George Kuiper§,
- Jan-Åke Gustafsson§ and
- Stephen Safe‡¶
- From the ‡Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843-4466 and the §Center for Biotechnology and Medical Nutrition, Karolinska Institute, Novum, S-14186 Huddinge, Sweden
Abstract
17β-Estradiol (E2) induces expression of several genes via estrogen receptor (ER)-Sp1 protein interactions with GC-rich promoter elements in which Sp1 but not ER binds DNA. This study reports the ligand- and cell context-dependent ERα/Sp1 and ERβ/Sp1 action using an E2-responsive construct (pSp1) containing a GC-rich promoter. Both ERα and ERβ proteins physically interact with Sp1 (coimmunoprecipitation) and preferentially bind to the C-terminal region of this protein in pull-down assays. E2- and antiestrogen-dependent transcriptional activation of ERα/Sp1 was observed in MCF-7, MDA-MB-231, and LnCaP cells, but not in HeLa cells. E2 did not affect or significantly decrease ERβ/Sp1 action, and antiestrogens had minimal effects in the same 4 cell lines. Exchange of activation function-1 (AF-1) domains of ER subtypes gave chimeric ERα/β(AF-1α/AF-2β) and ERβ/α (AF-1β/AF-2α) proteins that resembled wild-type ER (α or β) in terms of physical association with Sp1 protein. Transcriptional activation studies with chimeric ERβ/α and ERα/β showed that only ERα/β can activate transcription from an Sp1 element, not ERβ/α. This indicates that the AF-1 domain from ERα is responsible for activation at an Sp1 element, independent of ER subtype context. In order to further characterize this observation, deletion constructs in the AF-1 domain of both ERα and ERα/β were made, and transactivation studies indicated that the region between amino acids 79 and 117 of this domain is important for activation at an Sp1 element.
Footnotes
-
↵* Supported by the Welch Foundation, National Institutes of Health Grants CA76636 and ES09106, the Swedish Cancer Fund, and the Texas Agricultural Experiment Station.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵¶ Sid Kyle Professor of Toxicology. To whom correspondence should be addressed: Dept. of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843-4466. Tel.: 409-845-5988; Fax: 409-862-4929; E-mail: ssafe@cvm.tamu.edu.
-
↵2 B. Saville, M. Wormke, F. Wang, T. Nguyen, E. Enmark, G. Kuiper, J.-Å. Gustafsson, and S. Safe, unpublished results.
- Abbreviations:
- ER
-
estrogen receptor
- AF
-
activation function
- E2
-
17β-estradiol
- ERE
-
estrogen-responsive element
- FBS
-
fetal bovine serum
- hER
-
human estrogen receptor
- aa
-
amino acid(s)
- bp
-
base pair(s)
- CAT
-
chloramphenicol acetyltransferase
- DME/F12
-
Dulbecco's modified Eagle's medium/Ham's F-12 medium
- PCR
-
polymerase chain reaction
- GST
-
glutathione S-transferase
- CAT
-
chloramphenicol acetyltransferase
-
- Received October 14, 1999.
- Revision received December 9, 1999.
- The American Society for Biochemistry and Molecular Biology, Inc.











